WEUSKOP7136: A global, prospective cohort study to evaluate the real-world use of eltrombopag in adult patients with chronic Hepatitis C Virus infection who are unable to initiate or maintain optimal interferon-based therapy due to thrombocytopenia (201111)

06/08/2014
30/03/2024
EU PAS number:
EUPAS7201
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.49 MB - PDF) View document
Study results
Study results
English (5.52 MB - PDF) View document
Study report
Other information